CORS  ( CROM20 ): A new high‐prevalence antigen in the Cromer blood group system | Zendy

Vrignaud Cédric | Zendy; Chiaroni Jacques | Zendy; DurieuxRoussel Elisabeth | Zendy; Le Van Kim Caroline | Zendy; Azouzi Slim | Zendy; Peyrard Thierry | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

CORS ( CROM20 ): A new high‐prevalence antigen in the Cromer blood group system

Author(s) -

Vrignaud Cédric,

Chiaroni Jacques,

DurieuxRoussel Elisabeth,

Le Van Kim Caroline,

Azouzi Slim,

Peyrard Thierry

Publication year - 2020

Publication title -

transfusion

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.045

H-Index - 132

eISSN - 1537-2995

pISSN - 0041-1132

DOI - 10.1111/trf.16052

Subject(s) - antigen , proband , blood group antigens , glycine , biology , gene , microbiology and biotechnology , chemistry , immunology , genetics , amino acid , mutation

The Cromer blood group system consists of 19 antigens (16 of high prevalence and 3 of low prevalence). This study describes the identification and characterization of a new Cromer high‐prevalence antigen, named CORS. The CORS‐negative proband carries a c.713G>A substitution in the CD55 gene, resulting in the substitution of glycine 238 into a glutamic acid (p.Gly238Glu).

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research